Literature DB >> 16080188

Whole blood fixation and permeabilization protocol with red blood cell lysis for flow cytometry of intracellular phosphorylated epitopes in leukocyte subpopulations.

Sue Chow1, David Hedley, Patricia Grom, Robert Magari, James W Jacobberger, T Vincent Shankey.   

Abstract

BACKGROUND: Previous studies of intracellular expression of phospho-epitopes in human leukocytes using flow cytometry have used erythrocyte removal or lysis before fixation. Because many of the phospho-epitopes of interest are part of signaling networks that respond to the environment and turn over rapidly, the interval and manipulations used to eliminate erythrocytes from samples have the potential to introduce artifacts. We report a procedure to fix samples containing red blood cells with formaldehyde and then remove erythrocytes by lysis. Detection of phospho-Thr 202/Tyr 204-p44/42 extracellular-regulated kinase (ERK) after phorbol ester acetate (PMA) stimulation was used as a model to measure phospho-epitopes in leukocyte populations in whole blood.
METHODS: Normal blood samples were activated with PMA followed by formaldehyde fixation and subsequent treatments with detergents and protein denaturants. The effects of each treatment were monitored by light scatter, selected CD expression intensity, and phosphorylated ERK (pERK) expression.
RESULTS: Red cells could be lysed using 0.1% Triton X-100 after brief fixation of whole blood with 2% or 4% formaldehyde. Light scatter improved as a function of formaldehyde concentration and inversely with MeOH concentration. CD3 signal intensity increased when MeOH concentration was reduced. The ratio of pERK immunofluorescence in PMA-stimulated versus nonstimulated (control) samples was highest with high MeOH (90%) and lowest without MeOH treatment. This pattern is consistent with epitope unmasking by alcohol. The pERK epitope could also be unmasked by treatment with high salt, urea, acid, or heat, but none of these produced the level of unmasking of MeOH and each of these was associated with degradation of light scatter and CD3 staining intensity. The final procedure employed 4% formaldehyde, 0.1% Triton X-100, followed by 50% methanol denaturation. Samples prepared in this way demonstrated good preservation of light scatter and surface immunophenotypic patterns, similar to those obtained using a commercial whole blood/red blood cell lysing system (Q-Prep) and an acceptable PMA-stimulated pERK signal (essentially 100% of CD3+ cells that are pERK positive).
CONCLUSIONS: Brief fixation of whole blood in 4% formaldehyde followed by treatment with Triton X-100 results in erythrocyte lysis and leukocyte light scatter and immunophenotypic features equivalent to those of other commercial lysis reagents. Intracellular pERK staining is significantly improved by treatment with methanol, but levels of MeOH above 50% degrade light scatter and CD3 expression. This protocol (formaldehyde/Triton X-100/MeOH) circumvents potential artifactual changes in phospho-epitopes due to removal of erythrocytes or erythrocyte lysis followed by fixation, and results in a pERK signal that resolves positive from negative cell populations. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16080188     DOI: 10.1002/cyto.a.20167

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  33 in total

1.  Single-cell pharmacodynamic monitoring of S6 ribosomal protein phosphorylation in AML blasts during a clinical trial combining the mTOR inhibitor sirolimus and intensive chemotherapy.

Authors:  Alexander E Perl; Margaret T Kasner; Doris Shank; Selina M Luger; Martin Carroll
Journal:  Clin Cancer Res       Date:  2011-12-13       Impact factor: 12.531

2.  Selective inhibition of extracellular signal-regulated kinases 1/2 blocks nerve growth factor to brain-derived neurotrophic factor signaling and suppresses the development of and reverses already established pain behavior in rats.

Authors:  Y Matsuoka; J Yang
Journal:  Neuroscience       Date:  2012-01-10       Impact factor: 3.590

3.  Serum Derived Transfer Factor Stimulates the Innate Immune System to Improve Survival Traits in High Risk Pathogen Scenarios.

Authors:  Bridget V Willeford; Trudy Shapiro-Dunlap; Kenneth O Willeford
Journal:  Drug Dev Res       Date:  2017-06-22       Impact factor: 4.360

4.  A phase I trial of the aurora kinase inhibitor, ENMD-2076, in patients with relapsed or refractory acute myeloid leukemia or chronic myelomonocytic leukemia.

Authors:  Karen W L Yee; Hsiao-Wei T Chen; David W Hedley; Sue Chow; Joseph Brandwein; Andre C Schuh; Aaron D Schimmer; Vikas Gupta; Deborah Sanfelice; Tara Johnson; Lisa W Le; Jamie Arnott; Mark R Bray; Carolyn Sidor; Mark D Minden
Journal:  Invest New Drugs       Date:  2016-07-12       Impact factor: 3.850

5.  Immune Cell Profiling of IFN-λ Response Shows pDCs Express Highest Level of IFN-λR1 and Are Directly Responsive via the JAK-STAT Pathway.

Authors:  Aoife Kelly; Mark W Robinson; Gerard Roche; Christine A Biron; Cliona O'Farrelly; Elizabeth J Ryan
Journal:  J Interferon Cytokine Res       Date:  2016-09-12       Impact factor: 2.607

6.  Relative quantification of beta-adrenergic receptor in peripheral blood cells using flow cytometry.

Authors:  Didem Saygin; Nicholas Wanner; Jonathan A Rose; Sathyamangla V Naga Prasad; W H Wilson Tang; Serpil Erzurum; Kewal Asosingh
Journal:  Cytometry A       Date:  2018-03-24       Impact factor: 4.355

7.  Normal bone marrow signal-transduction profiles: a requisite for enhanced detection of signaling dysregulations in AML.

Authors:  James Marvin; Suchitra Swaminathan; Geoffrey Kraker; Amy Chadburn; James Jacobberger; Charles Goolsby
Journal:  Blood       Date:  2011-01-13       Impact factor: 22.113

8.  Propagation of trimethylated H3K27 regulated by polycomb protein EED is required for embryogenesis, hematopoietic maintenance, and tumor suppression.

Authors:  Takeshi Ueda; Yuichiro Nakata; Akiko Nagamachi; Norimasa Yamasaki; Akinori Kanai; Yasuyuki Sera; Masato Sasaki; Hirotaka Matsui; Zen-Ichiro Honda; Hideaki Oda; Linda Wolff; Toshiya Inaba; Hiroaki Honda
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-30       Impact factor: 11.205

9.  Retinoic acid induces nuclear accumulation of Raf1 during differentiation of HL-60 cells.

Authors:  James Smith; Rodica P Bunaciu; Gudrun Reiterer; David Coder; Thaddeus George; Michael Asaly; Andrew Yen
Journal:  Exp Cell Res       Date:  2009-03-17       Impact factor: 3.905

10.  An integrin-targeted, pan-isoform, phosphoinositide-3 kinase inhibitor, SF1126, has activity against multiple myeloma in vivo.

Authors:  Pradip De; Nandini Dey; Breanne Terakedis; P Leif Bergsagel; Zhi Hua Li; Daruka Mahadevan; Joseph R Garlich; Suzanne Trudel; Milan T Makale; Donald L Durden
Journal:  Cancer Chemother Pharmacol       Date:  2013-01-25       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.